For research use only. Not for human consumption. Not medical advice — consult a licensed clinician.

Healing & Recovery

SNAP-8

Also known as: Acetyl Octapeptide-3

SNAP-8 is a topical cosmetic peptide derived from SNAP-25, marketed as an alternative to topical Argireline for expression-line reduction.

Where to buy · live market data

Who's worth your money for SNAP-8

Every current seller, ranked by independent evidence — Merit Score, latest COA purity, and live $/mg (size-normalized). Prices refresh daily. Rankings are never paid.

Top Merit pick

Highest Merit Score (97) of 23 scored sellers

$3.00/mg

$60.00 · 20mg · 99.8% purity

4 COAs
Buy Code MERIT · 15% off

Best value after code

$0.00/mg effective with 15% code

$0.00/mg

— · 10mg

no COAs yet
Buy Code MERIT · 15% off

Most tested

12 independent COAs on file

$3.30/mg

$33.00 · 10mg · 99.8% purity

Average price

$3.25/mg

Sellers

44

45-day trend

-25.1%

31 of 44 sellers have a current price· 3 stale hidden· 5 unverified hidden

Prices observed from public storefronts (last 24h), normalized to $/mg. "Evidence" is Merit's 0–100 Merit Score, derived only from observable verification evidence (methodology on /about); "Purity" is the latest independent COA. Some buy links are affiliate links — Merit may earn a commission at no extra cost to you, and where a vendor offers one, the code shown gets you a discount at their checkout. Affiliate status never affects price data, ranking, or the Merit Score (full policy on /disclosure). Research use only.

Watch SNAP-8

Get one email when the market actually moves — no newsletter, no noise.

Compound reference

About SNAP-8

CAS

868844-74-0

Molecular formula

C42H72N16O15S

Sequence

EEMQRRAD

Typical dose range

Topical: 0.001–0.01% in formulation (applied twice daily); no established systemic/injectable dose in published research

Half-life

Independent evidence

COAs for SNAP-8

56 third-party tests across 18 vendors. Each card links to the full report.

All 56 COAs for SNAP-8 →
Measured purity 95.9%–99.9% across 38 COAs
Measured purity over time
Aggregated · 3rd-party listing
99.80 %
Jun 2026
Janoshik Analytical Limited

For

SNAP-8

by Verified Peptides· batch SN806260510E

Aggregated · 3rd-party listing
99.53 %
May 2026
ILS Labs Strong

For

Snap-8

by Ion Peptide· batch SNP10-05042026

✓ Vendor-published
99.59 %
May 2026
ILS Laboratories

For

Snap-8

by Ion Peptide· batch SNP10-050A2026

COA on file
✓ Vendor-published
99.53 %
May 2026
ILS Laboratories

For

Snap-8

by Ion Peptide· batch SNP10-0504206

COA on file
Aggregated · 3rd-party listing
99.74 %
May 2026
ILS Labs Strong

For

Snap-8

by Ion Peptide· batch SNP8-04302026

✓ Vendor-published
99.74 %
May 2026
ILS Laboratories

For

Snap-8

by Ion Peptide· batch SNP-04302026

COA on file
Aggregated · 3rd-party listing
96.90 %
May 2026
Freedom Diagnostics Moderate

For

Snap-8

by Real Peptides· batch Black Cap

Aggregated · 3rd-party listing
99.60 %
Apr 2026
Biogenica Labs · HPLC

For

SNAP-8

by Amino Club· batch SN0001

Aggregated · 3rd-party listing
99.82 %
Feb 2026
Janoshik Analytical Limited · HPLC

For

SNAP-8

by Qihang Peptide· batch 2

Aggregated · 3rd-party listing
99.04 %
Feb 2026
Vanguard Laboratory Strong

For

SNAP-8

by Peptidology· batch 1669

Aggregated · 3rd-party listing
99.80 %
Feb 2026
Freedom Diagnostics Moderate

For

SNAP-8

by Modern Research Peptides· batch SNP8HK261

Aggregated · 3rd-party listing
99.71 %
Feb 2026
Janoshik Analytical Limited

For

Snap-8

by Peptide Crafters· batch PC-G2-SNP10

Aggregated · 3rd-party listing
99.45 %
Jan 2026
Janoshik Analytical Limited

For

SNAP-8

by EZ Peptides· batch EZP-SNAP1012302025-02

✓ Vendor-published
99.45 %
Jan 2026
Janoshik Analytical Limited

For

SNAP-8

by EZ Peptides· batch EZP-SNAP1012302025-02

COA on file
Aggregated · 3rd-party listing
99.65 %
Jan 2026
Freedom Diagnostics Moderate

For

SNAP8

by Ion Peptide· batch SNP8R-123125

Aggregated · 3rd-party listing
95.90 %
Dec 2025
Freedom Diagnostics Moderate

For

SNAP8

by Ion Peptide· batch S810-122025

Aggregated · 3rd-party listing
99.87 %
Nov 2025
Freedom Diagnostics Moderate

For

SNAP-8

by Peptide Tech· batch SNP-4860

✓ Vendor-published
99.63 %
Nov 2025
Chromate Moderate

For

SNAP-8

by Ruo Bio· batch SN8001

COA on file
Aggregated · 3rd-party listing
98.68 %
Nov 2025
Chromate Moderate · HPLC

For

SNAP-8

by Mile High Compounds· batch SNA-010-MH-01

✓ Vendor-published
98.68 %
Nov 2025
Chromate Moderate

For

SNAP-8

by Mile High Compounds· batch SNA-010-MH-01

COA on file
Aggregated · 3rd-party listing
98.72 %
Oct 2025
Vanguard Laboratory Strong

For

Snap-8

by Certified Peptides· batch SNP10102325

Aggregated · 3rd-party listing
99.80 %
Oct 2025
Janoshik Analytical Limited

For

SNAP-8

by Peptide Crafters· batch PC-G1-SNP10

✓ Vendor-published
99.94 %
Oct 2025
Freedom Diagnostics Moderate

For

SNAP-8

by Ion Peptide· batch SN1-1025

COA on file
Aggregated · 3rd-party listing
99.94 %
Oct 2025
Freedom Diagnostics Moderate

For

SNAP-8

by Ion Peptide· batch SN1-1025

Research depth

12 citations indexed for SNAP-8

All research on SNAP-8 →

Study · 2026

When One is Not Enough: Multi-Program Needs in Older Adults at Risk of Cognitive Decline

case-report · 2026

Hereditary Neuropathy with Liability to Pressure Palsies Mimicking a Chronic Inflammatory Demyelinating Polyneuropathy Variant: A Case Report Highlighting Diagnostic Challenges

We herein report a case of chronic inflammatory demyelinating polyneuropathy (CIDP) that was ultimately identified as hereditary neuropathy with liability to pressure palsies (HNPP) based on PMP22 gene testing.

cohort · 2026

Filtered-phase imaging versus susceptibility-weighted imaging for paramagnetic rim lesion detection in multiple sclerosis: A head-to-head comparison

Background Paramagnetic rim lesions (PRLs) detected on susceptibility-sensitive magnetic resonance imaging (MRI) represent chronic active lesions and correlate with disease progression in multiple sclerosis (MS). However, optimal detection methods remain unclear.

Study · 2026

Automated Cardiac Reorientation and Slice Extraction in Cine Coronary CT Angiography: Agreement with Cardiovascular Magnetic Resonance

Visualization of coronary computed tomography angiography (CCTA) in standard cardiac planes requires reorientation of the three-dimensional image volume because the heart is double-oblique relative to the axial scan plane.

Study · 2026

An Experimental Measurement Method to Characterize and Apply Platinum Silicon Material for a Biomechanical Replica of the Thoracic Aorta

Currently, silicone is a common material used in medical research and biomedical applications. This research aims to characterize extra-soft platinum silicone (shore A 00 50) and compare its mechanical behavior with that of the human thoracic aorta.

Study · 2025

Glycosylated <i>N</i>‑Acyl Phosphoethanolamines as Bacterial Food-Dependent Signaling Molecules in <i>Caenorhabditis</i> Nematodes

N -acyl ethanolamines represent conserved lipophilic signaling molecules that function as endogenous ligands at G-protein-coupled receptors, ion channels, and nuclear receptors.